Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6.
Explore this paper's citation graph
Summary
In Asian populations it may be important to optimize pharmacotherapy either by assessing patients' CYP2D6 genotype, or by prescribing medications that are not metabolized by this isozyme, creating the potential for significant adverse events.
- Type
- article
- Published
- 2003-01-01
- Cited by
- 74
- References
- 0
- OpenAlex
- https://openalex.org/W82198944
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20779859
Keywords
CYP2D6, Pharmacogenetics, Isozyme, Genotype, Cytochrome P450
References
No references recorded for this paper.
Cited by
- Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients
- Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
- What makes personalized medicine work? : an empirical analysis of the role of product attributes, medical professional societies and patient groups in the diffusion of four breast cancer genetic tests
- Relationship of CYP2D6 genetic polymorphisms and the pharmacokinetics of tramadol in Chinese volunteers
- Pharmacokinetics and Tolerability of Duloxetine following Oral Administration to Healthy Chinese Subjects
- Cancer pharmacogenomics: achievements in basic research
- Pharmacogenetics and rational drug use around the world.
- Polymorphisms of CYP2D6 gene and gefitinib-induced hepatotoxicity.
- Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers
- Drug-drug interactions in oncology: why are they important and can they be minimized?
- Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
- Frequency of CYP2D6*10 and *14 Alleles and their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population
- Frequency of Certain Single-Nucleotide Polymorphisms and Duplication of CYP2D6 in the Jordanian Population
- A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
- Tramadol in Japanese Population: the Relative Contribution of M1 Metabolite as Assessed by CYP2D6*10 Genotype
- AmpliChip for Cytochrome P-450 Genotyping: The Epoch of Personalized Prescriptions
- Dextromethorphan metabolic phenotyping in an Iranian population
- The question of ethnic variability and the Darwinian significance of physiological neonatal jaundice in East Asian populations.
- Pharmacokinetics of Novel Atrial‐Selective Antiarrhythmic Agent Vernakalant Hydrochloride Injection (RSD1235): Influence of CYP2D6 Expression and Other Factors
- Genotyping of eight polymorphic genes encoding drug-metabolizing enzymes and transporters using a customized oligonucleotide array.
Related papers
- Polymorphism of CYP2D6 and the influence to the drug metabolism
- Metabolism, Pharmacogenetics, and Metabolic Drug–Drug Interactions of Antipsychotic Drugs
- Polymorphism in the metabolism of drugs, including antidepressant drugs: comments on phenotyping.
- Pharmacogenetics of the Cytochrome P450 Enzyme System: Review of Current Knowledge and Clinical Significance
- Cytochrome P450: genetic polymorphism and drug interactions.
- Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes
- Pharmacogenetics: the molecular genetics of CYP2D6 dependent drug metabolism.
- Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.
- Polymorphisms of CYP and ethnic differences